GlassScriptPhysician profile
Warren A Ellsworth
NPI 1336470343
$284,476.84
in general payments reported to CMS, 2019-2025
28 companies · $30K in 2025
The $30K reported for 2025 was more than what 97% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $17K · 2021: $54K · 2022: $81K · 2023: $60K · 2024: $7,779 · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $40K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $23K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $22K · Food and Beverage: $8,118 · Travel and Lodging: $5,052 · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $39,906.69 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23,230.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $21,600.00 |
| Food and Beverage | $8,117.95 |
| Travel and Lodging | $5,051.79 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $152,060.60 | 2019-2022 | |
| Abbvie INC. | $56,416.58 | 2023-2025 | |
| Axogen | $48,440.38 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Connector |
| Integra Lifesciences Corporation | $9,499.57 | 2021-2025 | Surgimend, Codman Certas, Durasorb Monofilament Mesh |
| Sientra, INC. | $7,078.85 | 2019-2022 | |
| Mentor Worldwide LLC | $1,775.63 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Cpx 2 Breast Tissue Expander |
| Motiva USA, LLC | $1,536.52 | 2025 | |
| Merz North America, INC. | $1,358.34 | 2019-2021 | |
| Biocircuit Technologies INC | $1,250.00 | 2025 | Nerve Tape |
| Tepha INC | $1,074.70 | 2019 | |
| Aroa Biosurgery Incorporated | $858.00 | 2022-2025 | |
| Tela Bio, INC. | $547.73 | 2021-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $473.83 | 2022-2023 | Arista Ah Flexitip |
| Musculoskeletal Transplant Foundation INC. | $395.55 | 2019-2023 | |
| Bard Peripheral Vascular, INC. | $336.35 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $245.74 | 2019-2021 | |
| Revance Therapeutics, INC. | $212.71 | 2024 | Daxxify |
| Rti Surgical, INC | $210.80 | 2022 | |
| Kerecis Limited | $197.83 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Alafair Biosciences, INC. | $126.97 | 2024 | Versawrap |
| Ethicon US, LLC | $73.93 | 2025 | Ethicon, Dermabond, Evarrest |
| Becton, Dickinson and Company | $73.00 | 2025 | Phasix Mesh |
| Polynovo North America LLC | $66.97 | 2025 | Novosorb Btm |
| Smith+Nephew, INC. | $45.07 | 2023-2025 | Renasys Go V2 Home, Pico 14, Collagenase Santyl |
| Galderma Laboratories, L.P. | $40.25 | 2021 | |
| Biotissue Holdings INC. | $36.29 | 2024 | |
| Stryker Corporation | $27.35 | 2021 | |
| Kci USA, INC. | $17.30 | 2023 | V.A.C. Veraflo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Warren Ellsworth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.